Freeze-dry composition for treating NHL (non-hodgkin lymphoma) and preparation method thereof

A non-Hodgkin, composition technology, applied in the field of medicine, can solve the problems of inconvenience, increase the risk of use by patients, etc., and achieve the effects of improving safety and stable quality

Inactive Publication Date: 2016-07-20
QINGDAO TUMOR HOSPITAL
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] But the contriver finds in the test, needs to use 0.9% sodium chloride solution to dilute after intravenous infusion during clinical use of injection picantron maleate, and the visible foreign matter of its diluted solution increases with the prolongation of placement time, and this It brings great inconvenience to the clinical drug preparation of medical staff, and also increases the risk of use of patients. The inventor found through the investigation of the current technology that none of the current technologies can solve this problem.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Freeze-dry composition for treating NHL (non-hodgkin lymphoma) and preparation method thereof
  • Freeze-dry composition for treating NHL (non-hodgkin lymphoma) and preparation method thereof
  • Freeze-dry composition for treating NHL (non-hodgkin lymphoma) and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0017] prescription

[0018]

[0019] Preparation Process

[0020] Weigh the prescribed amount of sodium chloride, lactose and sodium acetate and dissolve them in an appropriate amount of water for injection, weigh the prescribed amount of picantone maleate and dissolve them in the above solution, stir and mix evenly, and dissolve them with an appropriate amount of dilute hydrochloric acid or dilute hydrogen The sodium oxide solution is used to adjust the pH value, and the volume is adjusted to the total amount with water for injection, stirred and mixed evenly, filtered, filled, freeze-dried, and the finished product is obtained by visual inspection.

Embodiment 2

[0022] prescription

[0023]

[0024] Preparation Process:

[0025] Weigh the prescribed amount of sodium chloride, lactose and sodium acetate and dissolve them in an appropriate amount of water for injection, weigh the prescribed amount of picantone maleate and dissolve them in the above solution, stir and mix evenly, and dissolve them with an appropriate amount of dilute hydrochloric acid or dilute hydrogen The sodium oxide solution is used to adjust the pH value, and the volume is adjusted to the total amount with water for injection, stirred and mixed evenly, filtered, filled, freeze-dried, and the finished product is obtained by visual inspection.

Embodiment 3

[0027] prescription

[0028]

[0029] Preparation Process:

[0030] Weigh the prescribed amount of sodium chloride, lactose and sodium acetate and dissolve them in an appropriate amount of water for injection, weigh the prescribed amount of picantone maleate and dissolve them in the above solution, stir and mix evenly, and dissolve them with an appropriate amount of dilute hydrochloric acid or dilute hydrogen The sodium oxide solution is used to adjust the pH value, and the volume is adjusted to the total amount with water for injection, stirred and mixed evenly, filtered, filled, freeze-dried, and the finished product is obtained by visual inspection.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the technical field of medicine, and particularly relates to a freeze-dry composition for treating NHL (non-hodgkin lymphoma) and a preparation method thereof. The freeze-dry composition for treating NHL mainly consists of active ingredients including maleic acid pixantrone, sodium chloride, lactose, natrium aceticum and pH regulators. The The freeze-dry composition for treating NHL has the advantages that the quality is stable; all indexes conform to the quality requirements; in the clinical use process, the preparation by medical personnel is convenient; the prepared medicine can be stored for a long time; meanwhile, the use safety of a patient is also improved.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a freeze-dried composition for treating non-Hodgkin's lymphoma and a preparation method thereof. Background technique [0002] Non-Hodgkin's lymphoma (NHL) is a group of highly heterogeneous neoplastic diseases. Due to the different functions of clonal proliferating lymphocytes and their wide distribution in the human body, they can affect any organ in the body, so they show various morphological characteristics, immunophenotypes, biological behaviors, clinical manifestations, different treatment responses and prognosis. Its main clinical features are superficial or deep lymphadenopathy, hyperplasia of extranodal lymphoid tissue, involvement of other organs in the body, and systemic symptoms. The course of NHL progresses at different speeds. Most patients present with multifocal malignant hyperplasia at onset, or initially originate from a group of lymph nodes or a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/19A61K31/473A61K47/26A61P35/00
CPCA61K9/0019A61K9/19A61K31/473A61K47/26
Inventor 夏建明
Owner QINGDAO TUMOR HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products